GSK

Proteomic signatures improve risk prediction for common and rare diseases

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } Press releases QMUL Press release UCL Press release Nature Medicine Research Briefing Blood proteins predict the risk of many diseases years before onset.

Proteomic prediction of common and rare diseases

section { background: white; color: black; border-radius: 1em; padding: 1em; left: 50% } #inner { display: inline-block; display: flex; align-items: center; justify-content: center } Twitter thread summarising key results

UCL-GSK Phenomics Hub

Phenotyping at scale across diverse biobank cohorts to power genomic & proteomic analyses for target identification, drug discovery, and precision medicine.